Christos Argyropoulos

chronic kidney disease diabetes diabetic nephropathy sglt2 inhibitors renal transplantation dialysis glp1 receptor agonists kidney health sodium glucose transporter inhibition kidney diagnostics kidney transplantation critical care nephrology statistics secondary hyperparathyroidism cardiovascular disease end stage renal disease biomarker gestational hypertension health microrna acute kidney injury primary care medicine clinical trials nephrology cardiology endocrinology finerenone aldosterone sglt2 mineralocorticoid antagonists hypercalcemia geriatric nephrology discovery hypertension big data biostatistics evidence-based medicine bayesian parathyroidectomy vitamin d receptor analogs calcimimetics hiv biomarker discovery exosomes cfrna rna sequencing end stage kidney disease cardiovascular outcomes canagliflozin ertugliflozin dapagliflozin empagliflozin mra outcomes data modeling simulation numerical integration monte carlo bayesian analysis machine learning angiotensin system inhibitors onconephrology tumor lysis syndrome check point inhibitors stem cell transplant oncology quality medical devices telenephrology information technology engagement patients telemedicine ask1 selonsertib ethics discharge esrd renal pharmacotherapy shared decision making critline monitoring blood volume pharmacology blood sugar insulin development open access students physiology renal physiology calcium phosphorus short rna sequencing ngs next generation sequencing sequencing rnaseq biology microscopy bedside diagnosis education and training test nephrolithiasis stone pregnancy preeclampsia generalized additive models r survival analysis drug development proteinuria payment models healthcare delivery steroid withdrawal human leukocyte antigen artificial intelligence galen acid-base stewart's model henderson - hasselbach icu alkalosis acidosis history microarrays database t-cells transcription factors behrens-fisher homocysteine p-cresol guanidines residual syndrome creatinine urea uremic toxin monoclonal gammopathies mic-a light chain deposition disease donor specific antibodies multiple myeloma allograft rejection subdistribution hazard regression competing risks drop out transplantation hemodialysis citric acid